000			01679 a2200469 4500
005			20250514004325.0
264		0	_c20011101
008			200111s 0 0 eng d
022			_a1397-3142
024	7		_a10.1034/j.1399-3046.2001.005004285.x _2doi
040			_aNLM _beng _cNLM
100	1		_aRemberger, M
245	0	0	_aPolyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation. _h[electronic resource]
260			_bPediatric transplantation _cAug 2001
300			_a285-92 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAntilymphocyte Serum _xtherapeutic use
650	0	4	_aCase-Control Studies
650	0	4	_aChi-Square Distribution
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aFemale
650	0	4	_aGraft Rejection _ximmunology
650	0	4	_aGraft vs Host Disease _ximmunology
650	0	4	_aHematopoietic Stem Cell Transplantation _xmortality
650	0	4	_aHistocompatibility Testing
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInfant
650	0	4	_aMale
650	0	4	_aRisk Factors
650	0	4	_aStatistics, Nonparametric
650	0	4	_aSurvival Rate
650	0	4	_aTransplantation Conditioning _xmethods
650	0	4	_aTransplantation, Homologous _ximmunology
650	0	4	_aTreatment Outcome
700	1		_aMattsson, J
700	1		_aRingdén, O
773	0		_tPediatric transplantation _gvol. 5 _gno. 4 _gp. 285-92
856	4	0	_uhttps://doi.org/10.1034/j.1399-3046.2001.005004285.x _zAvailable from publisher's website
999			_c11400083 _d11400083